Helsinn Group and ESTEVE sign a partnership agreement renewal to commercialize AKYNZEO® and ALOXI® in Germany
Helsinn Group and ESTEVE sign a partnership agreement renewal to commercialize AKYNZEO® and ALOXI® in Germany Lugano, Switzerland – January 8, 2025 – Helsinn Group (“Helsinn”), a global pharmaceutical company